282 related articles for article (PubMed ID: 12057157)
1. Malignant pleural mesothelioma.
Kindler HL
Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments for mesothelioma: standard and novel.
Kindler HL
Curr Treat Options Oncol; 2008 Jun; 9(2-3):171-9. PubMed ID: 18770046
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis, staging and therapy of malignant pleural mesothelioma].
Neumeister W; Gillissen A; Rasche K; Theile A; Müller KM; Schultze-Werninghaus G
Med Klin (Munich); 2002 Aug; 97(8):459-71. PubMed ID: 12229245
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the treatment of malignant pleural mesothelioma.
Ramalingam SS; Belani CP
J Thorac Oncol; 2008 Sep; 3(9):1056-64. PubMed ID: 18758312
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
Flores RM; Krug LM; Rosenzweig KE; Venkatraman E; Vincent A; Heelan R; Akhurst T; Rusch VW
J Thorac Oncol; 2006 May; 1(4):289-95. PubMed ID: 17409872
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
Flores RM
Lung Cancer; 2005 Jul; 49 Suppl 1():S71-4. PubMed ID: 15950805
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural mesothelioma.
Chen SE; Pace MB
Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
[TBL] [Abstract][Full Text] [Related]
10. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
11. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
[TBL] [Abstract][Full Text] [Related]
12. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma.
Stahel RA; Felley-Bosco E; Opitz I; Weder W
Future Oncol; 2009 Apr; 5(3):391-402. PubMed ID: 19374545
[TBL] [Abstract][Full Text] [Related]
15. Malignant pleural mesothelioma.
Ho L; Sugarbaker DJ; Skarin AT
Cancer Treat Res; 2001; 105():327-73. PubMed ID: 11224994
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma 2008.
Zervos MD; Bizekis C; Pass HI
Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
[TBL] [Abstract][Full Text] [Related]
18. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
19. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
Opitz I; Kestenholz P; Lardinois D; Müller M; Rousson V; Schneiter D; Stahel R; Weder W
Eur J Cardiothorac Surg; 2006 Apr; 29(4):579-84. PubMed ID: 16495068
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for malignant pleural mesothelioma.
Tomek S; Manegold C
Curr Opin Oncol; 2003 Mar; 15(2):148-56. PubMed ID: 12601280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
